documents: FDA-2022-N-2174-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-N-2174-0004 | FDA | FDA-2022-N-2174 | Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments | Notice | Request for Comments | 2023-01-26T05:00:00Z | 2023 | 1 | 2023-01-26T05:00:00Z | 2023-02-25T04:59:59Z | 2023-01-29T00:54:17Z | 2023-01553 | 0 | 0 | 090000648560cdb0 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref